Gene–environment interactions in Alzheimer disease: the emerging role of epigenetics

Alzheimer’s Association. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 17, 327–406 (2021).

Article  Google Scholar 

Reitz, C., Rogaeva, E. & Beecham, G. W. Late-onset vs nonmendelian early-onset Alzheimer disease: a distinction without a difference? Neurol. Genet. 6, e512 (2020).

PubMed  PubMed Central  Article  Google Scholar 

Ayodele, T., Rogaeva, E., Kurup, J. T., Beecham, G. & Reitz, C. Early-onset Alzheimer’s disease: what is missing in research? Curr. Neurol. Neurosci. Rep. 21, 4 (2021).

PubMed  PubMed Central  Article  Google Scholar 

Migliore, L. & Coppedè, F. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat. Res. 667, 82–97 (2009).

CAS  PubMed  Article  Google Scholar 

Jones, P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484–492 (2012).

CAS  PubMed  Article  Google Scholar 

Bannister, A. J. & Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res. 21, 381–395 (2011).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Peschansky, V. J. & Wahlestedt, C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics 9, 3–12 (2014).

CAS  PubMed  Article  Google Scholar 

Jirtle, R. L. & Skinner, M. K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 8, 253–262 (2007).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Feil, R. & Fraga, M. F. Epigenetics and the environment: emerging patterns and implications. Nat. Rev. Genet. 13, 97–109 (2012).

CAS  PubMed  Article  Google Scholar 

Cavalli, G. & Heard, E. Advances in epigenetics link genetics to the environment and disease. Nature 571, 489–499 (2019).

CAS  PubMed  Article  Google Scholar 

van Dongen, J. et al. Genetic and environmental influences interact with age and sex in shaping the human methylome. Nat. Commun. 7, 11115 (2016).

PubMed  PubMed Central  Article  Google Scholar 

Perera, B., Faulk, C., Svoboda, L. K., Goodrich, J. M. & Dolinoy, D. C. The role of environmental exposures and the epigenome in health and disease. Environ. Mol. Mutagen. 61, 176–192 (2020).

CAS  PubMed  Article  Google Scholar 

Barker, D. J. The developmental origins of adult disease. Eur. J. Epidemiol. 18, 733–736 (2003).

CAS  PubMed  Article  Google Scholar 

Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349, 704–706 (1991).

CAS  PubMed  Article  Google Scholar 

Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature 375, 754–760 (1995).

CAS  PubMed  Article  Google Scholar 

Rogaev, E. I. et al. Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature 376, 775–778 (1995).

CAS  PubMed  Article  Google Scholar 

Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353–356 (2002).

CAS  PubMed  Article  Google Scholar 

Cacace, R., Sleegers, K. & Van Broeckhoven, C. Molecular genetics of early‐onset Alzheimer’s disease revisited. Alzheimers Dement. 12, 733–748 (2016).

PubMed  Article  Google Scholar 

Strittmatter, W. J. et al. Apolipoprotein E: high-avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 8098–8102 (1993).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923 (1993).

CAS  PubMed  Article  Google Scholar 

Genin, E. et al. APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol. Psychiatry 16, 903–907 (2011).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C. C. & Bu, G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurol. 15, 501–518 (2019).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat. Genet. 41, 1088–1093 (2009).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat. Genet. 41, 1094–1099 (2009).

CAS  PubMed  Article  Google Scholar 

Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet. 45, 1452–1458 (2013).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kunkle, B. et al. Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing. Nat. Genet. 51, 414–430 (2019).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Marioni, R. E. et al. GWAS on family history of Alzheimer’s disease. Transl. Psychiatry 8, 99 (2018).

PubMed  PubMed Central  Article  Google Scholar 

Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat. Genet. 51, 404–413 (2019).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Schwartzentruber, J. et al. Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer’s disease risk genes. Nat. Genet. 53, 392–402 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat. Genet. 53, 1276–1282 (2021).

CAS  PubMed  Article  Google Scholar 

Guerreiro, R. et al. TREM2 variants in Alzheimer’s disease. N. Engl. J. Med. 368, 117–127 (2013).

CAS  PubMed  Article  Google Scholar 

Bis, J. C. et al. Whole exome sequencing study identifies novel rare and common Alzheimer’s-associated variants involved in immune response and transcriptional regulation. Mol. Psychiatry 25, 1859–1875 (2020).

CAS  PubMed  Article  Google Scholar 

Sims, R., Hill, M. & Williams, J. The multiplex model of the genetics of Alzheimer’s disease. Nat. Neurosci. 23, 311–322 (2020).

CAS  PubMed  Article  Google Scholar 

Escott-Price, V. et al. Common polygenic variation enhances risk prediction for Alzheimer’s disease. Brain 138, 3673–3684 (2015).

PubMed  PubMed Central  Article  Google Scholar 

Escott-Price, V., Myers, A. J., Huentelman, M. & Hardy, J. Polygenic risk score analysis of pathologically confirmed Alzheimer disease. Ann. Neurol. 82, 311–314 (2017).

PubMed  PubMed Central  Article  Google Scholar 

Escott-Price, V. & Schmidt, K. M. Probability of Alzheimer’s disease based on common and rare genetic variants. Alzheimers Res. Ther. 13, 140 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Pyun, J. M. et al. Predictability of polygenic risk score for progression to dementia and its interaction with APOE epsilon4 in mild cognitive impairment. Transl. Neurodegener. 10, 32 (2021).

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ebenau, J. L. et al. Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score. Alzheimers Dement. 13, e12229 (2021).

Google Sc

留言 (0)

沒有登入
gif